Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 14, 2013 - Issue 3
Submit an article Journal homepage
3,049
Views
322
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder

Heinz GrunzeNewcastle University, Institute of Neuroscience, Newcastle upon Tyne, UK;Ludwig-Maximilians-University, Department of Psychiatry, Munich, GermanyCorrespondence[email protected]
,
Eduard VietaBipolar Disorders Programme, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
,
Guy M. GoodwinUniversity of Oxford, Department of Psychiatry, Warneford Hospital, Oxford, UK
,
Charles BowdenUniversity of Texas Health Science Center, Department of Psychiatry, San Antonio, TX, USA
,
Rasmus W. LichtMood Disorders Research Unit, Aarhus University Hospital, Risskov, Denmark
,
Hans-Jürgen MöllerLudwig-Maximilians-University, Department of Psychiatry, Munich, Germany
,
Siegfried KasperMedical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria
& on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders* show all
Pages 154-219 | Received 22 Jan 2013, Accepted 23 Jan 2013, Published online: 13 Mar 2013

Citations (322)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (27)

Arnaud Pouchon, Rayan Nasserdine, Clément Dondé, Antoine Bertrand, Mircea Polosan & Stéphanie Bioulac. (2023) A systematic review of pharmacotherapy for attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders. Expert Opinion on Pharmacotherapy 24:13, pages 1497-1509.
Read now
Heinz Grunze & Michael Soyka. (2022) The pharmacotherapeutic management of comorbid bipolar disorder and alcohol use disorder. Expert Opinion on Pharmacotherapy 23:10, pages 1181-1193.
Read now
Massimiliano Buoli, Eleonora Gattoni, Enrico Collantoni, Alessio Maria Monteleone, Marco Solmi, Luisa Longo, Michele Ribolsi, Jacopo Santambrogio, Francesco Saverio Bersani, Andrea Aguglia, Gianluca Serafini, Maria Salvina Signorelli, Bernardo Dell’Osso, Mario Luciano & Silvana Galderisi. (2021) Factors influencing lithium versus valproate prescription preference in the maintenance treatment of bipolar patients: a report from the Italian Early Career Psychiatrists (SOPSI-GG). International Journal of Psychiatry in Clinical Practice 25:1, pages 82-89.
Read now
Laura Orsolini, Simone Pompili & Umberto Volpe. (2020) The ‘collateral side’ of mood stabilizers: safety and evidence-based strategies for managing side effects. Expert Opinion on Drug Safety 19:11, pages 1461-1495.
Read now
Alina Wilkowska & Wiesław J Cubała. (2019) Clozapine As Transformative Treatment In Bipolar Patients. Neuropsychiatric Disease and Treatment 15, pages 2901-2905.
Read now
Taro Kishi, Ikuo Nomura, Kenji Sakuma, Tsuyoshi Kitajima, Kazuo Mishima & Nakao Iwata. (2019) Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials. Neuropsychiatric Disease and Treatment 15, pages 1479-1486.
Read now
Raoul Belzeaux, Catherine Sanguinetti, Andrea Murru, Norma Verdolini, Isabella Pacchiarotti, Diego Hidalgo-Mazzei, Lola Cohen, Gerard Anmella, Margherita Barbuti, Eduard Vieta, Pierre-Michel Llorca & Ludovic Samalin. (2019) Pharmacotherapy for the peripartum management of bipolar disorder. Expert Opinion on Pharmacotherapy 20:14, pages 1731-1741.
Read now
Siegfried Kasper. (2019) A thank-you note from the Chief-Editor. The World Journal of Biological Psychiatry 20:4, pages 254-257.
Read now
Trevor R. Norman & James S. Olver. (2019) Agomelatine for depression: expanding the horizons?. Expert Opinion on Pharmacotherapy 20:6, pages 647-656.
Read now
Mallik Greene, Luciano Paladini, Teresa Lemmer, Alexandra Piedade, Maelys Touya & Otavio Clark. (2018) Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA. Neuropsychiatric Disease and Treatment 14, pages 1545-1559.
Read now
Anne Michal Morsel, Manuel Morrens & Bernard Sabbe. (2018) An overview of pharmacotherapy for bipolar I disorder. Expert Opinion on Pharmacotherapy 19:3, pages 203-222.
Read now
Maurizio Pompili, Claudio Verzura, Giada Trovini, Andrea Buscajoni, Giulia Falcone, Stefano Naim, Adele Nardella, Serena Sorice, Ross J Baldessarini & Paolo Girardi. (2018) Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders. Expert Opinion on Drug Safety 17:2, pages 197-205.
Read now
Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Jean-Michel Azorin, Lakshmi Yatham, Sergey Mosolov, Hans-Jürgen Möller & Siegfried Kasper. (2018) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder. The World Journal of Biological Psychiatry 19:1, pages 2-58.
Read now
Marco Solmi, Andrea Murru, Isabella Pacchiarotti, Juan Undurraga, Nicola Veronese, Michele Fornaro, Brendon Stubbs, Francesco Monaco, Eduard Vieta, Mary V Seeman, Christoph U Correll & André F Carvalho. (2017) Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review. Therapeutics and Clinical Risk Management 13, pages 757-777.
Read now
Pierre Baumann, Marie Spies, Hans-Jürgen Möller, Siegfried Kasper, Istvan Bitter & Gerd Laux. (2017) A proposal for a psychopharmacology–pharmacotherapy catalogue of learning objectives and a curriculum in Europe. The World Journal of Biological Psychiatry 18:1, pages 29-38.
Read now
Andrea Murru, Diego Hidalgo, Miquel Bernardo, Julio Bobes, Jerónimo Saiz-Ruiz, Cecilio Álamo & Eduard Vieta. (2016) Antipsychotic switching in schizoaffective disorder: A systematic review. The World Journal of Biological Psychiatry 17:7, pages 495-513.
Read now
Lucio Oldani, A. Carlo Altamura, Mohamed Abdelghani & Allan H. Young. (2016) Brain stimulation treatments in bipolar disorder: A review of the current literature. The World Journal of Biological Psychiatry 17:7, pages 482-494.
Read now
Ludovic Samalin, Andrea Murru & Eduard Vieta. (2016) Management of inter-episodic periods in patients with bipolar disorder. Expert Review of Neurotherapeutics 16:6, pages 659-670.
Read now
Jong-Hyun Jeong, Jeong Goo Lee, Moon-Doo Kim, Inki Sohn, Se-Hoon Shim, Hee Ryung Wang, Young Sup Woo, Duk-In Jon, Jeong Seok Seo, Young-Chul Shin, Kyung Joon Min, Bo-Hyun Yoon & Won-Myong Bahk. (2015) Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines. Neuropsychiatric Disease and Treatment 11, pages 1561-1571.
Read now
Young Sup Woo, Jung Goo Lee, Jong-Hyun Jeong, Moon-Doo Kim, Inki Sohn, Se-Hoon Shim, Duk-In Jon, Jeong Seok Seo, Young-Chul Shin, Kyung Joon Min, Bo-Hyun Yoon & Won-Myong Bahk. (2015) Korean Medication Algorithm Project for Bipolar Disorder: third revision. Neuropsychiatric Disease and Treatment 11, pages 493-506.
Read now
Eva Maria Pichler, Georg Hattwich, Heinz Grunze & Moritz Muehlbacher. (2015) Safety and tolerability of anticonvulsant medication in bipolar disorder. Expert Opinion on Drug Safety 14:11, pages 1703-1724.
Read now
Michael Bauer, Emanuel Severus, Stephan Köhler, Peter C. Whybrow, Jules Angst & Hans-Jürgen Möller. (2015) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015. The World Journal of Biological Psychiatry 16:2, pages 76-95.
Read now
Kiran Kumar Sayyaparaju, Heinz Grunze & Kostas N Fountoulakis. (2014) When to start aripiprazole therapy in patients with bipolar mania. Neuropsychiatric Disease and Treatment 10, pages 459-470.
Read now
Genevieve Curran & Arun Ravindran. (2014) Lithium for bipolar disorder: a review of the recent literature. Expert Review of Neurotherapeutics 14:9, pages 1079-1098.
Read now
Ludovic Samalin, Aurore Tremey & Pierre-Michel Llorca. (2014) Quetiapine extended release for the treatment of bipolar disorder. Expert Review of Neurotherapeutics 14:9, pages 987-1005.
Read now
Bernardo Dell’Osso, Laura Cremaschi, Maria Carlotta Palazzo, Gregorio Spagnolin, Alma Cattaneo, Benedetta Grancini, Matteo Maggi & Alfredo Carlo Altamura. (2014) Use of asenapine as add-on therapy in the treatment of bipolar disorder: a comprehensive review and case series. Expert Opinion on Drug Safety 13:9, pages 1199-1208.
Read now
. (2013) Abstracts. International Journal of Psychiatry in Clinical Practice 17:sup2, pages 1-39.
Read now

Articles from other publishers (295)

Nemanja LjubicBianca UeberbergHeinz GrunzeHans-Jörg Assion. (2023) Treatment of Bipolar Disorders in Older Adults: A Review. FOCUS 21:4, pages 434-443.
Crossref
V.D. Santana Florido, A. Rodríguez Quiroga, D. Mancho & S. Fernández Rojo. (2023) Trastornos afectivos, trastornos depresivos y trastorno bipolar. Medicine - Programa de Formación Médica Continuada Acreditado 13:84, pages 4948-4956.
Crossref
Eduard Vieta, Sanman Ghorpade, Arunangshu Biswas, Angshuman Sarkar, Abhay Phansalkar & James Cooper. (2023) Lamotrigine efficacy, safety, and tolerability for women of childbearing age with bipolar I disorder: Meta-analysis from four randomized, placebo-controlled maintenance studies. European Neuropsychopharmacology.
Crossref
Christopher Rohde, Ole Köhler‐Forsberg, Andrew A. Nierenberg & Søren Dinesen Østergaard. (2023) Pharmacological treatment of bipolar disorder and risk of diabetes mellitus: A nationwide study of 30,451 patients. Bipolar Disorders 25:4, pages 323-334.
Crossref
Janusz K. Rybakowski. (2023) Mood Stabilizers of First and Second Generation. Brain Sciences 13:5, pages 741.
Crossref
Chih-Ming Cheng, Wei-Hung Chang, Yi-Ting Lin, Po-See Chen, Yen-Kuang Yang & Ya-Mei Bai. (2023) Taiwan consensus on biological treatment of bipolar disorder during the acute, maintenance, and mixed phases: The 2022 update. Asian Journal of Psychiatry 82, pages 103480.
Crossref
Giordano D'Urso, Elena Toscano, Annarita Barone, Mario Palermo, Bernardo Dell'Osso, Giorgio Di Lorenzo, Antonio Mantovani, Giovanni Martinotti, Michele Fornaro, Felice Iasevoli & Andrea de Bartolomeis. (2023) Transcranial direct current stimulation for bipolar depression: systematic reviews of clinical evidence and biological underpinnings. Progress in Neuro-Psychopharmacology and Biological Psychiatry 121, pages 110672.
Crossref
Özge Şahmelikoğlu Onur, Ümit Haluk Yeşilkaya, Emre Subaş, Özge Pınar Akarsu Açar, İsmail Umut Onur, Nesrin Karamustafalioğlu & Erdem Eriş. (2023) Can optical coherence tomography findings be related with suicide attempt in bipolar disorder?. Photodiagnosis and Photodynamic Therapy 41, pages 103268.
Crossref
Jong-Hyun Jeong, Won-Myong Bahk, Young Sup Woo, Bo-Hyun Yoon, Jung Goo Lee, Won Kim, InKi Sohn, Sung-Yong Park, Se-Hoon Shim, Jeong Seok Seo, IL Han Choo, Chan-Mo Yang, Myung Hun Jung, Duk-In Jon & Moon-Doo Kim. (2023) Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines. Clinical Psychopharmacology and Neuroscience 21:1, pages 32-48.
Crossref
Syed Zaidi, Adrian H Heald, Ravindra B Belgamwar & Anthony A Fryer. (2023) Monitoring drug interventions in people with bipolar disorder. BMJ, pages e070678.
Crossref
Alessandro Bosi, Laura Ceriani, Carl‐Gustaf Elinder, Rino Bellocco, Catherine M. Clase, Mikael Landen, Juan‐Jesus Carrero & Björn Runesson. (2023) Quality of laboratory biomarker monitoring during treatment with lithium in patients with bipolar disorder. Bipolar Disorders.
Crossref
A. Ratheesh, D. Hett, J. Ramain, E. Wong, L. Berk, P. Conus, M. A. Fristad, T. Goldstein, M. Hillegers, S. Jauhar, L. V. Kessing, D. J. Miklowitz, G. Murray, J. Scott, M. Tohen, L. N. Yatham, A. H. Young, M. Berk & S. Marwaha. (2023) A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early intervention. International Journal of Bipolar Disorders 11:1.
Crossref
Lek Wei Javier Loo, Qian Hui Chew, Shih-Ku Lin, Su-Yu Yang, Wen-Chen Ouyang, Chih-Ken Chen, Seon-Cheol Park, Ok-Jin Jang, Jun Hyuk Park, Kok-Yoon Chee, Kwong Sen Ding, Jamaline Chong, Ling Zhang, Keqing Li, Xiaomin Zhu, Chonnakarn Jatchavala, Pornjira Pariwatcharakul, Roy A. Kallivayalil, Sandeep Grover, Ajit Avasthi, Moin Ansari, Margarita M. Maramis, Paing Phyo Aung, Norman Sartorius, Yu-Tao Xiang, Chay-Hoon Tan, Mian-Yoon Chong, Yong Chon Park, Takahiro A. Kato, Naotaka Shinfuku, Ross J. Baldessarini & Kang Sim. (2023) Clozapine Use for Bipolar Disorder. Journal of Clinical Psychopharmacology Publish Ahead of Print.
Crossref
Ling Zhang, Honggeng Zhang, Lu-xian Lv, Qingrong Tan, Xiufeng Xu, Jian Hu, Lu Zi, James Cooper, Abhay Phansalkar & Gang Wang. (2022) A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of lamotrigine in the maintenance treatment of Chinese adult patients with bipolar I disorder. International Journal of Bipolar Disorders 10:1.
Crossref
Piotr Joachimiak, Krystyna Jaracz & Jan Jaracz. (2022) Neuropsychological exponents for the driving ability in remitted bipolar patients. International Journal of Bipolar Disorders 10:1.
Crossref
L. Samalin, A. Arnould, L. Boudieu, C. Henry, E. Haffen, D. Drapier, G. Anmella, I. Pacchiarotti, E. Vieta, R. Belzeaux & P.-M. Llorca. (2022) Avis d’experts français sur la prise en charge des femmes en âge de procréer et enceintes souffrant d’un trouble bipolaire traitées par valproate. L'Encéphale 48:6, pages 624-631.
Crossref
Yang-Chieh Brian Chen, Chih-Sung Liang, Liang-Jen Wang, Kuo-Chuan Hung, Andre F. Carvalho, Marco Solmi, Eduard Vieta, Ping-Tao Tseng, Pao-Yen Lin, Yu-Kang Tu, Chih-Wei Hsu & Edward Chia-Cheng Lai. (2022) Comparative effectiveness of valproic acid in different serum concentrations for maintenance treatment of bipolar disorder: A retrospective cohort study using target trial emulation framework. eClinicalMedicine 54, pages 101678.
Crossref
Jangwon Lee, Chan Woo Lee, Yoonjeong Jang, Ji Seon You, Yun Seong Park, Eunjeong Ji, Hyeona Yu, Sunghee Oh, Hyun A. Ryoo, Nayoung Cho, Ji Yoon Park, Joohyun Yoon, Ji Hyun Baek, Hye Youn Park, Tae Hyon Ha & Woojae Myung. (2022) Efficacy and safety of daily home-based transcranial direct current stimulation as adjunct treatment for bipolar depressive episodes: Double-blind sham-controlled randomized clinical trial. Frontiers in Psychiatry 13.
Crossref
Calogero Crapanzano, Ilaria Casolaro, Chiara Amendola & Stefano Damiani. (2022) Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors. Clinical Psychopharmacology and Neuroscience 20:3, pages 403-414.
Crossref
Mikkel Højlund, Jane Sterndorff Winkel, Mads Nybo, Jesper Hallas, Daniel Pilsgaard Henriksen & Per Damkier. (2022) Lithium and the risk of chronic kidney disease: A population‐based case–control study. Basic & Clinical Pharmacology & Toxicology 131:2, pages 129-137.
Crossref
Susana Gomes-da-Costa, Wolfgang Marx, Filippo Corponi, Gerard Anmella, Andrea Murru, Maria Teresa Pons-Cabrera, Anna Giménez-Palomo, Felipe Gutiérrez-Arango, Cristian Daniel Llach, Giovanna Fico, Georgios D. Kotzalidis, Norma Verdolini, Marc Valentí, Michael Berk, Eduard Vieta & Isabella Pacchiarotti. (2022) Lithium therapy and weight change in people with bipolar disorder: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 134, pages 104266.
Crossref
Shih-Ku Lin, Shu-Yu Yang, Seon-Cheol Park, Ok-Jin Jang, Xiaomin Zhu, Yu-Tao Xiang, Wen-Chen Ouyang, Afzal Javed, M. Nasar Sayeed Khan, Sandeep Grover, Ajit Avasthi, Roy Abraham Kallivayalil, Kok Yoon Chee, Norliza Chemi, Takahiro A. Kato, Kohei Hayakawa, Pornjira Pariwatcharakul, Margarita Maramis, Lakmi Seneviratne, Sim Kang, Wai Kwong Tang, Tin Oo, Norman Sartorius, Chay-Hoon Tan, Mian-Yoon Chong, Yong Chon Park & Naotaka Shinfuku. (2022) Prescription Patterns for Bipolar Disorder in Asian Countries: Findings from Research on Asian Prescription Pattern-Bipolar Disorder. Clinical Psychopharmacology and Neuroscience 20:1, pages 61-69.
Crossref
Fabiano A. Gomes, Raphael O. Cerqueira, Yena Lee, Rodrigo B. Mansur, Flavio Kapczinski, Roger S. McIntyre, Lakshmi N. Yatham, Michael Berk, Roumen Milev & Elisa Brietzke. (2022) What not to use in bipolar disorders: A systematic review of non-recommended treatments in clinical practice guidelines. Journal of Affective Disorders 298, pages 565-576.
Crossref
Jung Goo Lee, Won-Myong Bahk, Young Sup Woo, Jong-Hyun Jeong, Jeong Seok Seo, IL Han Choo, Chan-Mo Yang, Won Kim, Se-Hoon Shim, Myung Hun Jung, Duk-In Jon, Sung-Yong Park, InKi Sohn, Moon-Doo Kim & Bo-Hyun Yoon. (2022) Korean Medication Algorithm Project for Bipolar Disorder 2022: Maintenance Therapy. Journal of Korean Neuropsychiatric Association 61:3, pages 214.
Crossref
Jong-Hyun Jeong, Won-Myong Bahk, Young Sup Woo, Bo-Hyun Yoon, Jeong Seok Seo, IL Han Choo, Chan-Mo Yang, Won Kim, Jung Goo Lee, Se-Hoon Shim, Sung-Yong Park, InKi Sohn, Moon-Doo Kim, Myung Hun Jung & Duk-In Jon. (2022) Korean Medication Algorithm Project for Bipolar Disorder 2022: Rapid Cycling. Journal of Korean Neuropsychiatric Association 61:3, pages 204.
Crossref
Shobit Garg, Nishant Goyal, SaiKrishna Tikka & Preeti Mishra. (2022) Pragmatic issues and prescribing patterns in bipolar disorder: A mental health professional's survey. Industrial Psychiatry Journal 31:2, pages 235.
Crossref
Robert Hudak & Jessica M. GannonRobert Hudak & Jessica M. Gannon. 2022. Handbook of Psychiatric Disorders in Adults in the Primary Care Setting. Handbook of Psychiatric Disorders in Adults in the Primary Care Setting 47 80 .
Giovanna Fico, Gerard Anmella, Andrea Murru & Eduard Vieta. 2022. Recovery and Major Mental Disorders. Recovery and Major Mental Disorders 155 172 .
Georgios Schoretsanitis & Michael Paulzen. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1469 1491 .
Jelena Vrublevska & Lubova Renemane. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 823 853 .
Lluc Colomer, Gerard Anmella, Eduard Vieta & Iria Grande. (2021) Physical health in affective disorders: a narrative review of the literature. Brazilian Journal of Psychiatry 43:6, pages 621-630.
Crossref
Martin Sköld, Sindre Rolstad, Erik Joas, Mathias Kardell, Erik Pålsson, Guy M. Goodwin & Mikael Landén. (2021) Regional lithium prescription rates and recurrence in bipolar disorder. International Journal of Bipolar Disorders 9:1.
Crossref
Nemanja Ljubic, Bianca Ueberberg, Heinz Grunze & Hans-Jörg Assion. (2021) Treatment of bipolar disorders in older adults: a review. Annals of General Psychiatry 20:1.
Crossref
Jurriaan M. J. L. Brouwer, Erien Olde Hengel, Arne J. Risselada, Eric N. van Roon & Hans Mulder. (2021) Applicability of somatic monitoring instructions in clinical practice guidelines on antipsychotic drug use. BMC Psychiatry 21:1.
Crossref
Gordon Parker, Tahlia Ricciardi, Gabriela Tavella & Michael J Spoelma. (2021) The utility of daily mood ratings in clinical trials of patients with bipolar II disorder. Australasian Psychiatry 29:6, pages 648-651.
Crossref
Lars Vedel Kessing, Natacha Blauenfeldt Kyster, Pernille Bondo-Kozuch, Ellen Margrethe Christensen, Birgitte Vejstrup, Birte Smidt, Anne-Marie Bangsgaard Jørgensen, Raben Rosenberg, Darius Mardosas, Louise Behrend Rasmussen, Maj Vinberg, Ida Hageman & Maria Faurholt-Jepsen. (2021) Effect of specialised versus generalised outpatient treatment for bipolar disorder: the CAG Bipolar trial - study protocol for a randomised controlled trial. BMJ Open 11:10, pages e048821.
Crossref
Çağdaş Hünkar YELOĞLU, Çiçek HOCAOĞLU & Bülent BAHÇECİ. (2021) Bipolar Bozukluk Tanısı ile İzlenen Hastalarda İşlevsellik ve Kişilik Özelliklerinin Koruyucu Tedavi Üzerine Olan Etkisinin İncelenmesiEffect of personality traits on functioning and long-term treatment in patients with bipolar disorder. Genel Tıp Dergisi 31:3, pages 189-195.
Crossref
Bernardo Dell'Osso, Chiara Arici, Rita Cafaro, Matteo Vismara, Laura Cremaschi, Beatrice Benatti, Monica Macellaro, Caterina Viganò & Terence A. Ketter. (2021) Antidepressants in bipolar disorder: Analysis of correlates overall, and in BD-I and BD-II subsamples. Journal of Affective Disorders 292, pages 352-358.
Crossref
Gerard Anmella, Silvia Vilches, Jordi Espadaler-Mazo, Andrea Murru, Isabella Pacchiarotti, Miquel Tuson, Marina Garriga, Eva Solé, Mercè Brat, Giovanna Fico & Eduard Vieta. (2021) Genetic Variations Associated with Long-Term Treatment Response in Bipolar Depression. Genes 12:8, pages 1259.
Crossref
Gordon Parker, Tahlia Ricciardi, Gabriela Tavella & Dusan Hadzi-Pavlovic. (2021) A Single-Blind Randomized Comparison of Lithium and Lamotrigine as Maintenance Treatments for Managing Bipolar II Disorder. Journal of Clinical Psychopharmacology 41:4, pages 381-388.
Crossref
Daniel Mølager Christensen, Grimur Høgnason Mohr, Lars Vedel Kessing, Kristian Hay Kragholm, Christoffer Polcwiartek, Kathrine Bach Søndergaard, Mads Wissenberg, Freddy Lippert, Thomas Alexander Gerds, Christian Torp-Pedersen, Gunnar Hilmar Gislason & Carlo Alberto Barcella. (2021) Association of lithium use with rate of out-of-hospital cardiac arrest in patients with bipolar disorder. Journal of Affective Disorders Reports 5, pages 100164.
Crossref
Sergey Mosolov, Christoph Born & Heinz Grunze. (2021) Electroconvulsive Therapy (ECT) in Bipolar Disorder Patients with Ultra-Rapid Cycling and Unstable Mixed States. Medicina 57:6, pages 624.
Crossref
Norma Verdolini, Diego Hidalgo‐Mazzei, Laura Del Matto, Michele Muscas, Isabella Pacchiarotti, Andrea Murru, Ludovic Samalin, Alberto Aedo, Mauricio Tohen, Heinz Grunze, Allan H. Young, André F. Carvalho & Eduard Vieta. (2021) Long‐term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms. Bipolar Disorders 23:4, pages 324-340.
Crossref
Maria Antonietta Furio, Dina Popovic, Eduard Vieta, Yelena Stukalin, Michal Hagin, Carla Torrent, Jean‐Michel Azorin, Jules Angst, Charles L. Bowden, Sergey Mosolov, Allan H. Young & Giulio Perugi. (2020) Characterization of rapid cycling bipolar patients presenting with major depressive episode within the BRIDGE‐II‐MIX study. Bipolar Disorders 23:4, pages 391-399.
Crossref
Elisabet Casellas, Beatriz Raventós, Marina Piñeiro-Ríos, Helena Navarro-Martínez, Maite Castillón-Espezel, Maria J. Portella & Ana Martín-Blanco. (2021) A Real-World Study of the Association between a Brief Group Psychoeducation and the Course of Bipolar Disorder. International Journal of Environmental Research and Public Health 18:9, pages 5019.
Crossref
Asta Ratna Prajapati, Alexandra Dima, George Mosa, Sion Scott, Fujian Song, Jonathan Wilson & Debi Bhattacharya. (2021) Mapping modifiable determinants of medication adherence in bipolar disorder (BD) to the theoretical domains framework (TDF): a systematic review. Psychological Medicine 51:7, pages 1082-1098.
Crossref
Anna Grunze, Benedikt L. Amann & Heinz Grunze. (2021) Efficacy of Carbamazepine and Its Derivatives in the Treatment of Bipolar Disorder. Medicina 57:5, pages 433.
Crossref
Michal Taler, Ramona Aronovich, Shay Henry Hornfeld, Shira Dar, Efrat Sasson, Abraham Weizman & Eldar Hochman. (2020) Regulatory effect of lithium on hippocampal blood‐brain barrier integrity in a rat model of depressive‐like behavior. Bipolar Disorders 23:1, pages 55-65.
Crossref
A.N. Barkhatova. (2021) About diagnosis and therapy of bipolar disorder. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121:3, pages 155.
Crossref
Frank M.C. Besag, Michael J. Vasey, Aditya N. Sharma & Ivan C.H. Lam. (2021) Efficacy and safety of lamotrigine in the treatment of bipolar disorder across the lifespan: a systematic review. Therapeutic Advances in Psychopharmacology 11, pages 204512532110458.
Crossref
Mutahira M. Qureshi & Allan H. Young. (2021) Hamlet’s augury: how to manage discontinuation of mood stabilizers in bipolar disorder. Therapeutic Advances in Psychopharmacology 11, pages 204512532110006.
Crossref
Ana González-Pinto, Vicent Balanzá-Martínez, Antoni Benaberre Hernández, Luis Gutiérrez-Rojas, José Manuel Montes, Consuelo de Dios Perrino, Víctor Pérez Sola, Ángel Luis Montejo González, Anna Giménez Palomo & José Manuel Crespo. (2021) Expert consensus on information sheet proposals for patients under treatment with lithium. Revista de Psiquiatría y Salud Mental (English Edition) 14:1, pages 27-39.
Crossref
Ana González-Pinto, Vicent Balanzá-Martínez, Antoni Benabarre Hernández, Luis Gutiérrez-Rojas, José Manuel Montes, Consuelo de Dios Perrino, Víctor Pérez Sola, Ángel Luis Montejo González, Anna Giménez Palomo & José Manuel Crespo. (2021) Consenso de expertos sobre propuestas de información al paciente en tratamiento con sales de litio. Revista de Psiquiatría y Salud Mental 14:1, pages 27-39.
Crossref
Hubertus Himmerich, Carol Kan, Katie Au & Janet Treasure. (2021) Pharmacological treatment of eating disorders, comorbid mental health problems, malnutrition and physical health consequences. Pharmacology & Therapeutics 217, pages 107667.
Crossref
Ching-Hua Lin, Hung-Yu Chan, Chun-Chi Hsu & Feng-Chua Chen. (2021) Time to rehospitalization in patients with bipolar mania discharged on long-acting injectable or oral antipsychotics. Journal of Affective Disorders 279, pages 292-298.
Crossref
Priya Sunder, Ming-Fang Chia, Kate Filia, Craig Macneil, Melissa Hasty, Christopher Davey, Patrick McGorry, Michael Berk, Sue Cotton & Aswin Ratheesh. (2021) Does guideline-concordant care predict naturalistic outcomes in youth with early stage bipolar I disorder?. Journal of Affective Disorders 278, pages 23-32.
Crossref
Lorenzo Del Fabro, Giuseppe Delvecchio, Marcella Bellani & Paolo Brambilla. 2021. Neurobiology of Bipolar Disorder. Neurobiology of Bipolar Disorder 427 437 .
Andrea Murru, Gerard Anmella, Anna Giménez & Eduard Vieta. 2021. Neurobiology of Bipolar Disorder. Neurobiology of Bipolar Disorder 257 274 .
Isabella Pacchiarotti, Gerard Anmella & Eduard Vieta. 2021. Neurobiology of Bipolar Disorder. Neurobiology of Bipolar Disorder 97 107 .
Guang Chen, Rodrigo Machado-Vieira, Carlos A. Zarate & Husseini K. Manji. 2021. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 1004 1010 .
Guang Chen, Rodrigo Machado-Vieira, Carlos A. Zarate & Husseini K. Manji. 2020. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 1 7 .
Jinyoung Lee, Ji Hyun Baek, Dongbin Lee, Sung Woo Ahn, So-Yung Yang, Yujin Choi, Yong Chun Bahk & Kyung Sue Hong. (2020) Defining phenotypes of long-term lithium and valproate response, including combination therapy: a modified application of the Alda scale in patients with bipolar disorders. International Journal of Bipolar Disorders 8:1.
Crossref
Alfredo B. Cuéllar-Barboza, Susan L. McElroy, Marin Veldic, Balwinder Singh, Simon Kung, Francisco Romo-Nava, Nicolas A. Nunez, Alejandra Cabello-Arreola, Brandon J. Coombes, Miguel Prieto, Hannah K. Betcher, Katherine M. Moore, Stacey J. Winham, Joanna M. Biernacka & Mark A. Frye. (2020) Potential pharmacogenomic targets in bipolar disorder: considerations for current testing and the development of decision support tools to individualize treatment selection. International Journal of Bipolar Disorders 8:1.
Crossref
Shota Hanyu, Naoko Sugita, Miyuki Matsuda, Toshiya Murai & Hironobu Fujiwara. (2020) Lithium intoxication–induced dysgeusia accompanied by glossalgia in a patient receiving lithium carbonate: a case report. Journal of Medical Case Reports 14:1.
Crossref
Luca SteardoJrJr, Mario Luciano, Gaia Sampogna, Francesca Zinno, Pasquale Saviano, Filippo Staltari, Cristina Segura Garcia, Pasquale De Fazio & Andrea Fiorillo. (2020) Efficacy of the interpersonal and social rhythm therapy (IPSRT) in patients with bipolar disorder: results from a real-world, controlled trial. Annals of General Psychiatry 19:1.
Crossref
Hitoshi Sakurai, Masaki Kato, Norio Yasui-Furukori, Takefumi Suzuki, Hajime Baba, Koichiro Watanabe, Ken Inada, Ikuko Kishida, Yuka Sugawara Kikuchi, Toshiaki Kikuchi, Asuka Katsuki & Hiroyuki Uchida. (2020) Pharmacological management of bipolar disorder: Japanese expert consensus. Bipolar Disorders 22:8, pages 822-830.
Crossref
Y. W. Francis Lam. (2020) Olanzapine and lithium interaction. The Brown University Psychopharmacology Update 31:11, pages 2-3.
Crossref
Yena LeeElisa BrietzkeBing CaoYan ChenOuti LinnarantaRodrigo B MansurPaulina CortesMarkus KöstersAmna MajeedJocelyn K TamuraLeanna M W LuiMaj VinbergJaakko KeinänenSteve KiselySadiq NaveedCorrado BarbuiGary ParkerMayowa OwolabiDaisuke NishiJungGoo LeeManit SrisurapanontHartej GillLan GuoVicent Balanzá-MartínezTimo PartonenWillem A NolenJae-Hon LeeJi Hwan KimNiels H ChavannesTatjana EwaisBeatriz Atienza-CarbonellAnna V SilvenNaonori YasumaArtyom GilAndrey NovikovCameron LaceyAnke VersluisSofia von MalortieLai Fong ChanAhmed WaqasMarianna PurgatoJiska Joëlle AardoomJosefina T Ly-UsonKang SimMaria TuineagRianne M J J van der KleijSanne van LuenenSirijit SuttajitTomas HajekYu Wei LeeRichard J PorterMohammad AlsuwaidanJoshua D RosenblatArun V RavindranRaymond W LamRoger S McIntyre. (2020) Development and implementation of guidelines for the management of depression: a systematic review. Bulletin of the World Health Organization 98:10, pages 683-697H.
Crossref
I. Pacchiarotti, G. Anmella, L. Colomer & E. Vieta. (2020) How to treat mania. Acta Psychiatrica Scandinavica 142:3, pages 173-192.
Crossref
Taro Kishi, Kenji Sakuma, Makoto Okuya, Yuki Matsuda, Satoru Esumi, Yasuhiko Hashimoto, Masakazu Hatano, Nobumi Miyake, Itaru Miura, Kengo Miyahara, Kiyoshi Fujita, Kunihiro Kawashima, Kazuo Mishima & Nakao Iwata. (2020) Recurrence of Mania or Depression Among Adult Bipolar Patients Who Continued Using Lithium. Journal of Clinical Psychopharmacology 40:5, pages 468-474.
Crossref
Vera De Carlo, Matteo Vismara, Benedetta Grancini, Beatrice Benatti, Monica Francesca Bosi, Anna Colombo, Caterina Adele Viganò & Bernardo Dell'Osso. (2020) Effectiveness, tolerability, and dropout rates of vortioxetine in comorbid depression: A naturalistic study. Human Psychopharmacology: Clinical and Experimental 35:5.
Crossref
Eun Young Kim, Nam Woo Kim, Min Ji Kim, Bo Ram Yang, Sang Jin Rhee, C. Hyung Keun Park, Hyun Jeong Lee, Se Hyun Kim & Yong Min Ahn. (2020) Rate of diagnostic conversion to bipolar disorder in adults with unipolar depression and psychopharmacological treatment in the republic of Korea: A nationwide register-based study. Journal of Affective Disorders 273, pages 240-246.
Crossref
Shay Gur, Michal Taler, Gil Bormant, Dori Blattberg, Uri Nitzan, Adi Vaknin-Dembinsky, Livnat Brill, Amir Krivoy, Abraham Weizman & Eldar Hochman. (2020) Lack of association between unipolar or bipolar depression and serum aquaporin-4 autoantibodies. Brain, Behavior, and Immunity 88, pages 930-934.
Crossref
Zachary A. CordnerDean F. MacKinnonJ. Raymond DePauloJr.Jr.. (2020) The Care of Patients With Complex Mood Disorders. FOCUS 18:2, pages 129-138.
Crossref
Michał Lew-Starowicz, Karol Lewczuk, Iwona Nowakowska, Shane Kraus & Mateusz Gola. (2020) Compulsive Sexual Behavior and Dysregulation of Emotion. Sexual Medicine Reviews 8:2, pages 191-205.
Crossref
Crystal T. Clark. (2020) Psychotropic drug use in perinatal women with bipolar disorder. Seminars in Perinatology 44:3, pages 151230.
Crossref
Satyanarayana R. Yaramala, Susan L. McElroy, Jennifer Geske, Stacey Winham, Keming Gao, Noreen A. Reilly-Harrington, Terence A. Ketter, Thilo Deckersbach, Gustavo Kinrys, Masoud Kamali, Louisa G. Sylvia, Melvin G. McInnis, Edward S. Friedman, Machael E. Thase, James H. Kocsis, Mauricio Tohen, Joseph R. Calabrese, Charles L. Bowden, Richard C. Shelton, Andrew A. Nierenberg & William V. Bobo. (2020) The impact of binge eating behavior on lithium- and quetiapine-associated changes in body weight, body mass index, and waist circumference during 6 months of treatment: Findings from the bipolar CHOICE study. Journal of Affective Disorders 266, pages 772-781.
Crossref
Lister Rossel, Rodrigo Erazo, Rodrigo Nieto, Crisitán Fuentes & Pablo Curivil. (2020) Uso de criterios y guías clínicas en la creación de una unidad de trastornos del ánimo. Revista Médica Clínica Las Condes 31:2, pages 114-121.
Crossref
B. Soltmann, A. Pfennig & M. Bauer. (2020) Methodik des Leitlinien-Updates Bipolare Störungen und Ausblick auf künftige AktualisierungenMethodology of the guideline update on bipolar disorders and perspective on future updates. Der Nervenarzt 91:3, pages 222-226.
Crossref
Young Sup Woo, Bo-Hyun Yoon, Jye-Heon Song, Jeong Seok Seo, Beomwoo Nam, Kwanghun Lee, Jonghun Lee, Young-Eun Jung, Moon-Doo Kim, Jung Goo Lee, Sheng-Min Wang, Young-Joon Kwon & Won-Myong Bahk. (2020) Clinical correlates associated with the long-term response of bipolar disorder patients to lithium, valproate or lamotrigine: A retrospective study. PLOS ONE 15:1, pages e0227217.
Crossref
Jussi Valtonen & Mira Karrasch. (2020) Polypharmacy-induced cognitive dysfunction and discontinuation of psychotropic medication: a neuropsychological case report. Therapeutic Advances in Psychopharmacology 10, pages 204512532090573.
Crossref
Laura Cremaschi, Terence Arthur Ketter, Chiara Arici, Shefali Miller, Farnaz Hooshmand & Bernardo Dell’Osso. (2020) Antipsychotic use in Northern Italian inter-episode bipolar disorder patients. International Clinical Psychopharmacology 35:1, pages 49-58.
Crossref
Georgios Schoretsanitis & Michael Paulzen. 2019. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 24 .
Jelena Vrublevska & Lubova Renemane. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 31 .
Anna R. Van Meter & Eric A. Youngstrom. 2020. Handbook of Evidence-Based Therapies for Children and Adolescents. Handbook of Evidence-Based Therapies for Children and Adolescents 137 152 .
Nataliya Maruta. (2019) Modern approaches to the treatment of bipolar affective disorder (a review of the recommendations of professional psychiatric association’s). Ukrains'kyi Visnyk Psykhonevrolohii:Volume 27, issue 4 (101).
Crossref
Leonardo Tondo, Martin Alda, Michael Bauer, Veerle Bergink, Paul Grof, Tomas Hajek, Ute Lewitka, Rasmus W. Licht, Mirko Manchia, Bruno Müller-Oerlinghausen, René E. Nielsen, Marylou Selo, Christian Simhandl & Ross J. Baldessarini. (2019) Clinical use of lithium salts: guide for users and prescribers. International Journal of Bipolar Disorders 7:1.
Crossref
Sameer Jauhar & Allan H. Young. (2019) Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy. International Journal of Bipolar Disorders 7:1.
Crossref
P. Thomas. (2019) C.01.03 How to anticipate and involve patients in pregnancy planning?. European Neuropsychopharmacology 29, pages S590.
Crossref
Heinz Grunze & Schwäbisch Hall. (2019) Fortschritte in der Diagnostik und Behandlung bipolarer Störungen. DNP - Der Neurologe & Psychiater 20:6, pages 74-84.
Crossref
Louise Öhlund, Michael Ott, Malin Bergqvist, Sofia Oja, Robert Lundqvist, Mikael Sandlund, Ellinor Salander Renberg & Ursula Werneke. (2019) Clinical course and need for hospital admission after lithium discontinuation in patients with bipolar disorder type I or II: mirror-image study based on the LiSIE retrospective cohort. BJPsych Open 5:6.
Crossref
Gerard Anmella, Isabella Pacchiarotti, Wiesław Jerzy Cubała, Dominika Dudek, Giuseppe Maina, Pierre Thomas & Eduard Vieta. (2019) Expert advice on the management of valproate in women with bipolar disorder at childbearing age. European Neuropsychopharmacology 29:11, pages 1199-1212.
Crossref
Alison Hermann, Alyson Gorun & Abigail Benudis. (2019) Lithium Use and Non-use for Pregnant and Postpartum Women with Bipolar Disorder. Current Psychiatry Reports 21:11.
Crossref
Ming Fang Chia, Sue Cotton, Kate Filia, Mark Phelan, Philippe Conus, Sameer Jauhar, Steven Marwaha, Patrick D McGorry, Christopher Davey, Michael Berk & Aswin Ratheesh. (2019) Early intervention for bipolar disorder – Do current treatment guidelines provide recommendations for the early stages of the disorder?. Journal of Affective Disorders 257, pages 669-677.
Crossref
Marie Tournier, Anke Neumann, Elodie Pambrun, Alain Weill, Jean-Philippe Chaffiol, François Alla, Bernard Bégaud, Géric Maura & Hélène Verdoux. (2019) Conventional mood stabilizers and/or second-generation antipsychotic drugs in bipolar disorders: A population-based comparison of risk of treatment failure. Journal of Affective Disorders 257, pages 412-420.
Crossref
Willem A. Nolen, Rasmus W. Licht, Allan H. Young, Gin S. Malhi, Mauricio Tohen, Eduard Vieta, Ralph W. Kupka, Carlos Zarate, René E. Nielsen, Ross J. Baldessarini & Emanuel Severus. (2019) What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Bipolar Disorders 21:5, pages 394-409.
Crossref
Alina Wilkowska, Mariusz S. Wiglusz & Wiesław J. Cubała. (2019) Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports. Frontiers in Psychiatry 10.
Crossref
Danielle M. NovickHolly A. Swartz. (2019) Evidence-Based Psychotherapies for Bipolar Disorder. FOCUS 17:3, pages 238-248.
Crossref
VIRGINIO SALVI, GIANCARLO CERVERI, ANDREA AGUGLIA, SALVATORE CALÒ, MARIANGELA CORBO, GIOVANNI MARTINOTTI, GIANLUCA SERAFINI, MARIA SALVINA SIGNORELLI, EUGENIO AGUGLIA, MARIO AMORE, GIOVANNI BIGGIO, GUIDO DI SCIASCIO & CLAUDIO MENCACCI. (2019) Off-Label Use of Second-generation Antipsychotics in Bipolar Disorder: A Survey of Italian Psychiatrists. Journal of Psychiatric Practice 25:4, pages 318-327.
Crossref
İlkay Keleş Altun, Neslihan Kılıç, Emrah Yıldızoğlu & Murat İlhan Atagün. (2019) Lityuma Bağlı Yan Etkiler ve Nörotoksisite: Lityum Nörotoksisitesi Demir Birikimiyle İlgili Olabilir mi?Lithium Associated Side Effects and Neurotoxicity: Is Lithium Neurotoxicity Related to Iron Deposition?. Psikiyatride Güncel Yaklaşımlar 11:2, pages 141-153.
Crossref
Berit Kerner, Annette S Crisanti, Jason L DeShaw, Janika-Marie G Ho, Kimmie Jordan, Ronald L Krall, Matt J Kuntz, Aurélien J Mazurie, Anastasiya Nestsiarovich, Douglas J Perkins, Quentin L Schroeter, Alicia N Smith, Mauricio Tohen, Emma Volesky, Yiliang Zhu & Christophe G Lambert. (2019) Preferences of Information Dissemination on Treatment for Bipolar Disorder: Patient-Centered Focus Group Study. JMIR Mental Health 6:6, pages e12848.
Crossref
Asta Ratna Prajapati, Alexandra Lelia Dima, Allan B Clark, Claire Gant, Chris Gibbons, Richard Gorrod, George Mosa, Sion Scott, Fujian Song, Bonnie Teague, Michael J Twigg, Jon Wilson & Debi Bhattacharya. (2019) Mapping of modifiable barriers and facilitators of medication adherence in bipolar disorder to the Theoretical Domains Framework: a systematic review protocol. BMJ Open 9:2, pages e026980.
Crossref
Harold A. Sackeim, Scott T. Aaronson, Mark T. Bunker, Charles R. Conway, Mark A. Demitrack, Mark S. George, Joan Prudic, Michael E. Thase & A. John Rush. (2019) The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF). Journal of Psychiatric Research 113, pages 125-136.
Crossref
Laura Fusar-Poli, Teresa Surace, Antonio Vanella, Valeria Meo, Federica Patania, Rosaria Furnari, Maria Salvina Signorelli & Eugenio Aguglia. (2019) The effect of adjunctive nutraceuticals in bipolar disorder: A systematic review of randomized placebo-controlled trials. Journal of Affective Disorders 252, pages 334-349.
Crossref
Louise Wingård, Lena Brandt, Robert Bodén, Helle Kieler, Morten Andersen & Johan Reutfors. (2019) Monotherapy vs. combination therapy for post mania maintenance treatment: A population based cohort study. European Neuropsychopharmacology 29:6, pages 691-700.
Crossref
Jong-Hyun Jeong, Won-Myong Bahk, Young Sup Woo, Jung Goo Lee, Moon-Doo Kim, InKi Sohn, Se-Hoon Shim, Duk-In Jon, Jeong Seok Seo, Won Kim, Hoo-Rim Song, Kyung Joon Min & Bo-Hyun Yoon. (2019) Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines. Clinical Psychopharmacology and Neuroscience 17:2, pages 155-169.
Crossref
YC Janardhan Reddy, Venugopal Jhanwar, Rajesh Nagpal, MS Reddy, Nilesh Shah, Sanman Ghorpade & Sujay Kulkarni. (2019) Prescribing practices of Indian psychiatrists in the treatment of bipolar disorder. Australian & New Zealand Journal of Psychiatry 53:5, pages 458-469.
Crossref
Daria Szklarska & Piotr Rzymski. (2018) Is Lithium a Micronutrient? From Biological Activity and Epidemiological Observation to Food Fortification. Biological Trace Element Research 189:1, pages 18-27.
Crossref
Vera De Carlo, Benedetta Grancini, Matteo Vismara, Beatrice Benatti, Chiara Arici, Laura Cremaschi, Giovanna Cirnigliaro, Luca Degoni, Lucio Oldani, Carlotta Palazzo, Ira D. Glick, Caterina Viganò & Bernardo Dell'Osso. (2019) Exploring characteristics associated with first benzodiazepine prescription in patients with affective disorders and related diagnoses. Human Psychopharmacology: Clinical and Experimental 34:3.
Crossref
Isabella Pacchiarotti, Jari Tiihonen, Georgios D. Kotzalidis, Norma Verdolini, Andrea Murru, José Manuel Goikolea, Marc Valentí, Alberto Aedo & Eduard Vieta. (2019) Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review. European Neuropsychopharmacology 29:4, pages 457-470.
Crossref
Pernille Kempel Ellegaard, Rasmus Wentzer Licht, René Ernst Nielsen, Olivia May Dean, Michael Berk, Henrik Enghusen Poulsen, Mohammadreza Mohebbi & Connie Thuroee Nielsen. (2019) The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study. Journal of Affective Disorders 245, pages 1043-1051.
Crossref
Gabriela Tavella & Philip Boyce. 2018. Bipolar II Disorder. Bipolar II Disorder 151 162 .
Gabriela Tavella & Gordon Parker. 2018. Bipolar II Disorder. Bipolar II Disorder 108 112 .
Pao-Huan Chen, Tze-Fan Chao, Yu-Hsun Kao & Yi-Jen Chen. (2019) Lithium interacts with cardiac remodeling: the fundamental value in the pharmacotherapy of bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 88, pages 208-214.
Crossref
Katherine L. Wisner, Dorothy Sit, Kelly O'Shea, Debra L. Bogen, Crystal T. Clark, Emily Pinheiro, Amy Yang & Jody D. Ciolino. (2019) Bipolar disorder and psychotropic medication: Impact on pregnancy and neonatal outcomes. Journal of Affective Disorders 243, pages 220-225.
Crossref
. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen 1 119 .
M. Paulzen, G. Gründer & O. Benkert. 2019. Kompendium der Psychiatrischen Pharmakotherapie. Kompendium der Psychiatrischen Pharmakotherapie 209 283 .
Pierre Alexis Geoffroy, El Mountacer Billah El Abbassi, Julia Maruani, Bruno Etain, Michel Lejoyeux, Ali Amad, Philippe Courtet, Caroline Dubertret, Philip Gorwood, Guillaume Vaiva, Frank Bellivier & Sylvie Chevret. (2018) Bright Light Therapy in the Morning or at Mid-Day in the Treatment of Non-Seasonal Bipolar Depressive Episodes (LuBi): Study Protocol for a Dose Research Phase I / II Trial. Psychiatry Investigation 15:12, pages 1188-1202.
Crossref
M. Nederlof, E. R. Heerdink, A. C. G. Egberts, I. Wilting, L. J. Stoker, R. Hoekstra & R. W. Kupka. (2018) Monitoring of patients treated with lithium for bipolar disorder: an international survey. International Journal of Bipolar Disorders 6:1.
Crossref
M Nederlof, RW Kupka, AM Braam, ACG Egberts & ER Heerdink. (2018) Evaluation of clarity of presentation and applicability of monitoring instructions for patients using lithium in clinical practice guidelines for treatment of bipolar disorder. Bipolar Disorders 20:8, pages 708-720.
Crossref
Young Sup Woo, Won-Myong Bahk, Jung Goo Lee, Jong-Hyun Jeong, Moon-Doo Kim, InKi Sohn, Se-Hoon Shim, Duk-In Jon, Jeong Seok Seo, Kyung Joon Min, Won Kim, Hoo-Rim Song & Bo-Hyun Yoon. (2018) Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018): Fourth Revision. Clinical Psychopharmacology and Neuroscience 16:4, pages 434-448.
Crossref
Philip Boyce, Lauren Irwin, Grace Morris, Amber Hamilton, Roger Mulder, Gin S Malhi & Richard J Porter. (2018) Long‐acting injectable antipsychotics as maintenance treatments for bipolar disorder—A critical review of the evidence. Bipolar Disorders 20:S2, pages 25-36.
Crossref
Julia Dehning, Heinz Grunze, Michaela Walpoth-Niederwanger, Georg Kemmler & Armand Hausmann. (2018) The use of (newer) antipsychotics in bipolar inpatients over a 17-year observation period. International Clinical Psychopharmacology 33:6, pages 297-303.
Crossref
Michele Fornaro, Domenico De Berardis, Annalisa Anastasia, Stefano Novello, Andrea Fusco, Carlo Ignazio Cattaneo, Marco Solmi, Francesco Monaco, Nicola Veronese, Yong-Ku Kim & Andrea de Bartolomeis. (2018) The identification of biomarkers predicting acute and maintenance lithium treatment response in bipolar disorder: A plea for further research attention. Psychiatry Research 269, pages 658-672.
Crossref
Christian Lange-Asschenfeldt. (2018) Psychopharmakotherapie bei älteren Menschen mit schweren psychischen ErkrankungenPsychiatric pharmacotherapy of older individuals with severe mental illness. Zeitschrift für Gerontologie und Geriatrie 51:7, pages 770-778.
Crossref
Laura Musetti, Antonio Tundo, Alessandra Benedetti, Gabriele Massimetti, Erika Cambiali, Irene Pergentini, Claudia Del Grande & Liliana Dell'Osso. (2018) Lithium, valproate, and carbamazepine prescribing patterns for long‐term treatment of bipolar I and II disorders: A prospective study. Human Psychopharmacology: Clinical and Experimental 33:6.
Crossref
Tomáš Novák. (2018) Resistance in maintenance treatment of bipolar disorder. Psychiatrie pro praxi 19:3, pages 102-105.
Crossref
Kensuke Yoshimura, Tasuku Hashimoto, Yasunori Sato, Aiko Sato, Takashi Takeuchi, Hiroyuki Watanabe, Takeshi Terao, Michiko Nakazato & Masaomi Iyo. (2018) Survey of Anticonvulsant Drugs and Lithium Prescription in Women of Childbearing age in Japan Using a Public National Insurance Claims Database. Clinical Neuropsychopharmacology and Therapeutics 9:0, pages 20-28.
Crossref
N. Verdolini, D. Hidalgo-Mazzei, A. Murru, I. Pacchiarotti, L. Samalin, A. H. Young, E. Vieta & A. F. Carvalho. (2018) Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines. Acta Psychiatrica Scandinavica 138:3, pages 196-222.
Crossref
Lars Vedel Kessing, Michael Bauer, Willem A Nolen, Emanuel Severus, Guy M Goodwin & John Geddes. (2018) Effectiveness of maintenance therapy of lithium vs other mood stabilizers in monotherapy and in combinations: a systematic review of evidence from observational studies. Bipolar Disorders 20:5, pages 419-431.
Crossref
Alice Caldiroli, Marta Serati & Massimiliano Buoli. (2018) Is Internet Addiction a Clinical Symptom or a Psychiatric Disorder? A Comparison With Bipolar Disorder. Journal of Nervous & Mental Disease 206:8, pages 644-656.
Crossref
Ozlem Kazan Kizilkurt, Medine Yazici Gulec, Ferzan Ergun Giynas & Hüseyin Gulec. (2018) Effects of personality functioning on the global functioning of patients with bipolar disorder I. Psychiatry Research 266, pages 309-316.
Crossref
Alana Fisher, Louise Sharpe, Josephine Anderson, Vijaya Manicavasagar & Ilona Juraskova. (2018) Development and pilot of a decision-aid for patients with bipolar II disorder and their families making decisions about treatment options to prevent relapse. PLOS ONE 13:7, pages e0200490.
Crossref
Michael Paulzen, Georgios Schoretsanitis, Christoph Hiemke, Gerhard Gründer, Ekkehard Haen & Marc Augustin. (2018) Reduced clearance of venlafaxine in a combined treatment with quetiapine. Progress in Neuro-Psychopharmacology and Biological Psychiatry 85, pages 116-121.
Crossref
Michele Fornaro, Annalisa Anastasia, Francesco Monaco, Stefano Novello, Andrea Fusco, Felice Iasevoli, Domenico De Berardis, Nicola Veronese, Marco Solmi & Andrea de Bartolomeis. (2018) Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants. Journal of Affective Disorders 234, pages 131-138.
Crossref
Roger S. McIntyre, Allan H. Young & Peter M. Haddad. (2018) Rethinking the spectrum of mood disorders: implications for diagnosis and management – Proceedings of a symposium presented at the 30th Annual European College of Neuropsychopharmacology Congress, 4 September 2017, Paris, France. Therapeutic Advances in Psychopharmacology 8:1_suppl, pages 1-16.
Crossref
. (2018) Consider lithium as an option for the treatment of bipolar disorder in appropriate patients. Drugs & Therapy Perspectives 34:6, pages 248-252.
Crossref
K. L. Musliner & S. D. Østergaard. (2018) Patterns and predictors of conversion to bipolar disorder in 91 587 individuals diagnosed with unipolar depression. Acta Psychiatrica Scandinavica 137:5, pages 422-432.
Crossref
Benedetta Grancini, Vera De Carlo, Mariacarlotta Palazzo, Matteo Vismara, Chiara Arici, Laura Cremaschi, Beatrice Benatti, A. Carlo Altamura & Bernardo Dell’Osso. (2018) Does initial use of benzodiazepines delay an adequate pharmacological treatment? A multicentre analysis in patients with psychotic and affective disorders. International Clinical Psychopharmacology 33:3, pages 140-146.
Crossref
Dian-Jeng Li, Ching-Hua Lin & Feng-Chua Chen. (2018) Factors affecting time to remission for inpatients with bipolar mania – A naturalistic Taiwanese study. Journal of Affective Disorders 232, pages 73-78.
Crossref
Viktoriya L Nikolova, Keerati Pattanaseri, Diego Hidalgo-Mazzei, David Taylor & Allan H Young. (2018) Is lithium monitoring NICE? Lithium monitoring in a UK secondary care setting. Journal of Psychopharmacology 32:4, pages 408-415.
Crossref
Martin Alda & Mirko Manchia. (2018) Personalized management of bipolar disorder. Neuroscience Letters 669, pages 3-9.
Crossref
Gordon B. Parker & Gabriela Tavella. (2018) Design limitations to bipolar II treatment efficacy studies: A challenge and a revisionist strategy. Journal of Affective Disorders 229, pages 334-341.
Crossref
Rebecca K. Graham, Gabriela Tavella & Gordon B. Parker. (2018) Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period?. Journal of Affective Disorders 228, pages 216-221.
Crossref
Jose de Leon & Edoardo Spina. (2018) Possible Pharmacodynamic and Pharmacokinetic Drug-Drug Interactions That Are Likely to Be Clinically Relevant and/or Frequent in Bipolar Disorder. Current Psychiatry Reports 20:3.
Crossref
Lars Vedel Kessing, Per Kragh Andersen & Maj Vinberg. (2018) Risk of recurrence after a single manic or mixed episode - a systematic review and meta-analysis. Bipolar Disorders 20:1, pages 9-17.
Crossref
Brent Luu & George Rodway. (2018) Lithium Therapy for Bipolar Disorder. The Journal for Nurse Practitioners 14:2, pages 93-99.
Crossref
M Kristensen, A A Nierenberg & S D Østergaard. (2017) Face and predictive validity of the ClockΔ19 mouse as an animal model for bipolar disorder: a systematic review. Molecular Psychiatry 23:1, pages 70-80.
Crossref
Katarzyna Popiolek, Ole Brus, Tove Elvin, Mikael Landén, Johan Lundberg, Pia Nordanskog & Axel Nordenskjöld. (2018) Rehospitalization and suicide following electroconvulsive therapy for bipolar depression–A population-based register study. Journal of Affective Disorders 226, pages 146-154.
Crossref
Benjamin E. Housden, Zhongchi LiColleen KelleyYuanli WangYanhui HuAlexander J. ValvezanBrendan D. ManningNorbert Perrimon. (2017) Improved detection of synthetic lethal interactions in Drosophila cells using variable dose analysis (VDA) . Proceedings of the National Academy of Sciences 114:50.
Crossref
Dominik K. E. Beyer & Nadja Freund. (2017) Animal models for bipolar disorder: from bedside to the cage. International Journal of Bipolar Disorders 5:1.
Crossref
Andrei Pikalov, Joyce Tsai, Yongcai Mao, Robert Silva, Josephine Cucchiaro & Antony Loebel. (2017) Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment. International Journal of Bipolar Disorders 5:1.
Crossref
Pierre-Michel Llorca, Christophe Lançon, Ann Hartry, T. Michelle Brown, Dana B. DiBenedetti, Siddhesh A. Kamat & Clément François. (2017) Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications. BMC Psychiatry 17:1.
Crossref
Bangshan Liu, Yan Zhang, Han Fang, Jin Liu, Tiebang Liu & Lingjiang Li. (2017) Efficacy and safety of long-term antidepressant treatment for bipolar disorders – A meta-analysis of randomized controlled trials. Journal of Affective Disorders 223, pages 41-48.
Crossref
In Shim, Young Woo, Moon-Doo Kim & Won-Myong Bahk. (2017) Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression. International Journal of Molecular Sciences 18:11, pages 2406.
Crossref
Katharine A Smith & Andrea Cipriani. (2017) Lithium and suicide in mood disorders: Updated meta-review of the scientific literature. Bipolar Disorders 19:7, pages 575-586.
Crossref
Lars V Kessing, Thomas A Gerds, Nikoline N Knudsen, Lisbeth F Jørgensen, Søren M Kristiansen, Denitza Voutchkova, Vibeke Ernstsen, Jörg Schullehner, Birgitte Hansen, Per K Andersen & Annette K Ersbøll. (2017) Lithium in drinking water and the incidence of bipolar disorder: A nation-wide population-based study. Bipolar Disorders 19:7, pages 563-567.
Crossref
Jasmin Grigg, Roisin Worsley, Caroline Thew, Caroline Gurvich, Natalie Thomas & Jayashri Kulkarni. (2017) Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research. Psychopharmacology 234:22, pages 3279-3297.
Crossref
Atul R. Mahableshwarkar, Joseph R. Calabrese, Thomas A. Macek, Kumar Budur, Adedeji Adefuye, Xinxin Dong, Elizabeth Hanson & Gary S. Sachs. (2017) Efficacy and safety of sublingual ramelteon as an adjunctive therapy in the maintenance treatment of bipolar I disorder in adults: A phase 3, randomized controlled trial. Journal of Affective Disorders 221, pages 275-282.
Crossref
Louise B. Bjørklund, Henriette T. Horsdal, Ole Mors, Christiane Gasse & Søren D. Østergaard. (2017) Psychopharmacological treatment of psychotic mania and psychotic bipolar depression compared to non-psychotic mania and non-psychotic bipolar depression. Bipolar Disorders 19:6, pages 505-512.
Crossref
Joseph R. Calabrese, Andrei Pikalov, Caroline Streicher, Josephine Cucchiaro, Yongcai Mao & Antony Loebel. (2017) Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder. European Neuropsychopharmacology 27:9, pages 865-876.
Crossref
Tobias Atkin, Nicolas Nuñez & Gabriella Gobbi. (2017) Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder. Journal of Child Psychology and Psychiatry 58:8, pages 865-879.
Crossref
Clément Dondé, Ali Amad, Isabel Nieto, André Russowsky Brunoni, Nicholas H. Neufeld, Frank Bellivier, Emmanuel Poulet & Pierre-Alexis Geoffroy. (2017) Transcranial direct-current stimulation (tDCS) for bipolar depression: A systematic review and meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 78, pages 123-131.
Crossref
Ming H. Hsieh, Po-Ya Chuang, Chi-Shin Wu, Ching-Jui Chang, Pei-Fang Chung & Chao-Hsiun Tang. (2017) Bipolar patients treated with long-acting injectable risperidone in Taiwan: A 1-year mirror-image study using a national claims database. Journal of Affective Disorders 218, pages 327-334.
Crossref
Louise Wingård, Robert Bodén, Lena Brandt, Jari Tiihonen, Antti Tanskanen, Helle Kieler, Morten Andersen & Johan Reutfors. (2017) Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations. Journal of Affective Disorders 217, pages 16-23.
Crossref
Gin S. Malhi, Danielle Gessler & Tim Outhred. (2017) The use of lithium for the treatment of bipolar disorder: Recommendations from clinical practice guidelines. Journal of Affective Disorders 217, pages 266-280.
Crossref
Gabriele Sani, Giulio Perugi & Leonardo Tondo. (2017) Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice?. Clinical Drug Investigation 37:8, pages 713-727.
Crossref
Johannes Petzold, Michael Bauer & Emanuel Severus. (2017) Lithium in der Langzeittherapie der bipolaren Störung — was gibt es Neues?. DNP - Der Neurologe & Psychiater 18:7-8, pages 27-31.
Crossref
Lesley J. Robertson, Jacqui K. Miot & Bernard Janse van Rensburg. (2017) A retrospective record review and assessment of cost of quetiapine use in a community psychiatric setting in the Sedibeng district of Gauteng. South African Journal of Psychiatry 23.
Crossref
Y. W. Francis Lam. (2017) Mood stabilizers and risperidone. The Brown University Psychopharmacology Update 28:7, pages 2-3.
Crossref
Nikoline Knudsen, Jörg Schullehner, Birgitte Hansen, Lisbeth Jørgensen, Søren Kristiansen, Denitza Voutchkova, Thomas Gerds, Per Andersen, Kristine Bihrmann, Morten Grønbæk, Lars Kessing & Annette Ersbøll. (2017) Lithium in Drinking Water and Incidence of Suicide: A Nationwide Individual-Level Cohort Study with 22 Years of Follow-Up. International Journal of Environmental Research and Public Health 14:6, pages 627.
Crossref
Kara E Driscoll, Dorothy K Y Sit, Eydie L Moses-Kolko, Emily Pinheiro, Amy Yang, Jody D Ciolino, Heather F Eng, James F Luther, Crystal T Clark, Stephen R Wisniewski & Katherine L Wisner. (2017) Mood symptoms in pregnant and postpartum women with bipolar disorder: a naturalistic study. Bipolar Disorders 19:4, pages 295-304.
Crossref
G. B. Parker, R. K. Graham & G. Tavella. (2017) Is there consensus across international evidence-based guidelines for the management of bipolar disorder?. Acta Psychiatrica Scandinavica 135:6, pages 515-526.
Crossref

Displaying 200 of 322 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.